Monique M. Ryan
5 Robin Warren Drive
Perth, WA 6150, Australia
Perth, WA 6150, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications
Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children.
Journal: Steroids
Published: August 11, 2025
Survival in Duchenne muscular dystrophy in Australia: a 50 year retrospective cohort study.
Journal: The Lancet regional health. Western Pacific
Published: December 15, 2024
Hip Dysplasia in Charcot-Marie-Tooth Disease: Insights From a Large Cohort of Children and Adolescents.
Journal: Journal of the peripheral nervous system : JPNS
Published: November 18, 2024
Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double-blind placebo-controlled crossover trial.
Journal: Pharmacotherapy
Published: November 02, 2024
Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T.
Journal: Brain : a journal of neurology
Published: October 03, 2024
Longitudinal study on immunologic, lipoproteomic, and inflammatory responses indicates the safety of sequential COVID-19 vaccination.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: September 25, 2024
Bioanalysis Rising Star Award 2024: interviews with the finalists.
Journal: Bioanalysis
Published: July 01, 2024
The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy.
Journal: medRxiv : the preprint server for health sciences
Published: April 08, 2024
Stratification of Sepsis Patients on Admission into the Intensive Care Unit According to Differential Plasma Metabolic Phenotypes.
Journal: Journal of proteome research
Published: March 21, 2024
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone.
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone.
Journal: Annals of clinical and translational neurology
Published: February 02, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Journal: The Lancet. Neurology
Published: January 26, 2024
Last Updated: 09/26/2026